Vanguard Global Advisers’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.34M Buy
111,026
+22,608
+26% +$267K ﹤0.01% 1526
2026
Q2
$947K Buy
88,418
+4,773
+6% +$36.9K ﹤0.01% 1778
2026
Q1
$533K Buy
+83,645
New +$582K ﹤0.01% 2010

Other funds holding LFST

Vanguard Global Advisers's LFST Position: Q3 2026 in Review

Vanguard Global Advisers increased its Lifestance Health (LFST) stake by 26% in Q3 2026, buying an estimated $267K and bringing the position to 111,026 shares worth $1.34M. The position accounts for ﹤0.01% of the portfolio, ranked #1526.

Vanguard Global Advisers first reported a position in LFST in Q1 2026 and has held it in 3 quarters since. 324 funds tracked by Wall St. Rank hold LFST as of Q3 2026.

  • Vanguard Global Advisers held 111,026 shares of Lifestance Health worth $1.34M as of Q3 2026.
  • Vanguard Global Advisers bought 22,608 Lifestance Health shares in Q3 2026, an estimated $267K.
  • Lifestance Health made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #1526 holding.
  • Vanguard Global Advisers first reported a position in Lifestance Health in Q1 2026 and has held it in 3 quarters since.
  • 324 funds tracked by Wall St. Rank held Lifestance Health as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.